Afjal H. Miah
- Hematology top 10%
- Multiple Myeloma Research and Treatments 3
-
- Protein Degradation and Inhibitors 7
- Ubiquitin and proteasome pathways 5
- Chemical Synthesis and Analysis 2
- Oncology top 10%
- Chemokine receptors and signaling 3
- Peptidase Inhibition and Analysis 3
-
- Synthetic Organic Chemistry Methods 2
-
- Immune Cell Function and Interaction 2
- Co-authors
- John D. HarlingIan E. SmithJeffrey L. GustafsonKanak RainaNicole DarricarrèreDennis L. BuckleyJohn HinesCraig M. Crews
- Cited by
- HematologyMolecular BiologyOncology
- Journals
- Journal of the American Chemical Society (1 paper)Chemical Society Reviews (1 paper)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Afjal H. Miah
18 papers receiving 698 citations
Peers
Comparison fields: 5 of 50
- Hematology 121
- Molecular Biology 622
- Oncology 236
- Organic Chemistry 135
- Pharmaceutical Science 21
Countries citing papers authored by Afjal H. Miah
This map shows the geographic impact of Afjal H. Miah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afjal H. Miah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afjal H. Miah more than expected).
Fields of papers citing papers by Afjal H. Miah
This network shows the impact of papers produced by Afjal H. Miah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afjal H. Miah. The network helps show where Afjal H. Miah may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Afjal H. Miah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 21 | |
| 6 | 2023 | 26 | |
| 7 | 2021 | 49 | |
| 8 | 2020 | 6 | |
| 9 | 2019 | 2 | |
| 10 | 2018 | 121 | |
| 11 | 2017 | 8 | |
| 12 | 2016 | 6 | |
| 13 | 2015 | 342 | |
| 14 | 2014 | 7 | |
| 15 | 2014 | 12 | |
| 16 | 2009 | 52 | |
| 17 | 2009 | 7 | |
| 18 | 2004 | 19 |
About Afjal H. Miah
Afjal H. Miah is a scholar working on Hematology, Oncology and Organic Chemistry, having authored 18 papers that have together received 710 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (5 papers), Multiple Myeloma Research and Treatments (3 papers), Chemokine receptors and signaling (3 papers), Peptidase Inhibition and Analysis (3 papers), Chemical Synthesis and Analysis (2 papers), Immune Cell Function and Interaction (2 papers) and Synthetic Organic Chemistry Methods (2 papers). The work is most often cited by research in Hematology (121 citations), Molecular Biology (622 citations) and Oncology (236 citations). Afjal H. Miah has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include John D. Harling, Ian E. Smith, Jeffrey L. Gustafson, Kanak Raina, Nicole Darricarrère, Dennis L. Buckley, John Hines, Craig M. Crews, Ian Churcher and Jonathan M. Percy. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.